| Q34147757 | AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease |
| Q28181660 | Accumulation of the amyloid precursor-like protein APLP2 and reduction of APLP1 in retinoic acid-differentiated human neuroblastoma cells upon curcumin-induced neurite retraction |
| Q35099931 | Activation of M1 mAChRs by lesatropane rescues glutamate neurotoxicity in PC12 cells via PKC-mediated phosphorylation of ERK1/2 |
| Q40791619 | Activation of mitogen-activated protein kinase by muscarinic receptors in astroglial cells: role in DNA synthesis and effect of ethanol |
| Q36269317 | Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling |
| Q28287090 | Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease |
| Q64052629 | Constipation in Tg2576 mice model for Alzheimer's disease associated with dysregulation of mechanism involving the mAChR signaling pathway and ER stress response |
| Q40794695 | Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase. |
| Q28302829 | Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study |
| Q34995075 | Intracellular A-beta amyloid, a sign for worse things to come? |
| Q73701509 | Intracellular pathways involved in TNF-alpha and superoxide anion release by Abeta(1-42)-stimulated primary human macrophages |
| Q36906645 | Long-term anticholinergic use and the aging brain |
| Q37089887 | Long-term trihexyphenidyl exposure alters neuroimmune response and inflammation in aging rat: relevance to age and Alzheimer's disease |
| Q42131298 | Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline |
| Q35538840 | M<sub>1</sub> Muscarinic Agonists Can Modulate Some of the Hallmarks in Alzheimer's Disease: Implications in Future Therapy |
| Q38192962 | M1 muscarinic acetylcholine receptor in Alzheimer's disease |
| Q73104356 | M1 muscarinic receptors block caspase activation by phosphoinositide 3-kinase- and MAPK/ERK-independent pathways |
| Q40907904 | Mitogen-activated protein kinase is involved in N-methyl-D-aspartate receptor regulation of amyloid precursor protein cleavage |
| Q35019429 | Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer's disease |
| Q44111144 | Muscarine enhances soluble amyloid precursor protein secretion in human neuroblastoma SH-SY5Y by a pathway dependent on protein kinase C(alpha), src-tyrosine kinase and extracellular signal-regulated kinase but not phospholipase C. |
| Q48128442 | Neurohormonal Signaling Pathways and the Regulation of Alzheimer beta-Amyloid Precursor Metabolism |
| Q36893731 | Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase |
| Q40390510 | Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP. |
| Q43819249 | Quinuclidinone O-Alkynyloximes with muscarinic agonist activity |
| Q33739400 | Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism. |
| Q43651491 | Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists |
| Q37018138 | Redundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo |
| Q33971283 | Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism |
| Q44334391 | Role of protein kinase Calpha in the regulated secretion of the amyloid precursor protein |
| Q35202803 | Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans |
| Q34509353 | The Purinergic Receptor P2X7 Triggers α-Secretase-dependent Processing of the Amyloid Precursor Protein |
| Q34765346 | The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer |
| Q36622649 | The significance of the cholinergic system in the brain during aging and in Alzheimer's disease |
| Q52590407 | Therapeutic potential of multifunctional tacrine analogues. |
| Q34002967 | Use of anticholinergics and the risk of cognitive impairment in an African American population |